Previous Article | Next Article 
J Virol, April 1998, p. 3259-3267, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutational Analysis of the Candidate Internal
Fusion Peptide of the Avian Leukosis and Sarcoma Virus Subgroup A
Envelope Glycoprotein
Lorraine D.
Hernandez1,2 and
Judith M.
White2,*
Department of Biochemistry, University of
California, San Francisco, California 94143,1
and
Department of Cell Biology, University of Virginia Health
Sciences Center, Charlottesville, Virginia 229082
Received 8 July 1997/Accepted 23 December 1997
 |
ABSTRACT |
The transmembrane subunit (TM) of the avian leukosis and sarcoma
virus (ALSV) envelope glycoprotein (Env) contains a stretch of
conserved hydrophobic amino acids internal to its amino terminus (residues 21 to 42). By analogy with similar sequences in other viral
envelope glycoproteins, this region has been proposed to be a fusion
peptide. We investigated the role of this region by changing each of
three hydrophobic residues (Ile-21, Val-30, and Ile-39) to glutamatic
acid and lysine in the ALSV subgroup A Env. Like wild-type (wt) Env,
all six mutant Env proteins were proteolytically processed,
oligomerized, and expressed at the cell surface in a form that bound
Tva, the ALSV subgroup A receptor. Like wt Env, Ile21Glu, Ile21Lys,
Val30Glu, and Val30Lys changed conformation upon binding Tva, as
assayed by sensitivity to thermolysin. Ile39Glu and Ile39Lys were
cleaved by thermolysin in both the absence and presence of Tva.
Although incorporated into virus particles at approximately equal
levels, all mutant Envs were compromised in their ability to support
infection. The mutants at residues 21 and 30 showed levels of infection
2 to 3 orders of magnitude lower than that of wt Env. The mutants at
residue 39 were noninfectious. Furthermore, none of the mutants
displayed activity in a cell-cell fusion assay. Our results support the
contention that residues 21 to 42 of ALSV subgroup A Env constitute its
fusion peptide.
 |
INTRODUCTION |
Entry of enveloped viruses into host
cells requires fusion of the viral envelope with a host cell membrane.
This reaction is carried out by the spike envelope glycoproteins found
on the viral surface and can occur at either low or neutral pH,
depending on the virus (2, 16). Viruses that require low pH
for fusion bind to receptors at the cell surface and are then
internalized via the endocytic pathway. Biochemical and biophysical
studies have shown that in the low-pH environment of the endosome, the corresponding viral fusion proteins undergo conformational changes that
transform them into active fusion proteins (25). These changes include exposure of a previously buried hydrophobic region of
the protein called the fusion peptide. Interaction of the fusion peptide with the endosomal membrane initiates the fusion event (16). Viruses that do not require low pH are thought to
enter cells by fusing directly at the plasma membrane. Considerably less is known about the mechanisms of viral fusion proteins that function at neutral pH (18).
The avian leukosis and sarcoma viruses (ALSVs) are members of the
retrovirus family and, like most retroviruses, fuse with target cells
at neutral pH (11). ALSVs are divided into five major
subgroups designated A through E based on host range, receptor binding,
and interference patterns. The ALSV envelope (Env) glycoprotein is
synthesized as a glycosylated precursor, Pr95, that is proteolytically cleaved during transport to the plasma membrane, yielding the mature
surface (SU) and transmembrane (TM) subunits, with the SU subunit
containing receptor binding and subgroup specificity determinants
(29). The SU and TM subunits remain associated by a
disulfide bond(s) and are oligomerized as trimers (5). For
ALSV subgroup C (ALSV-C), it has been shown that posttranslational cleavage is required for infectivity (23).
The overall organization of ALSV Env is similar to those of the fusion
proteins of other viruses, especially those of other retroviruses and
members of the paramyxovirus and orthomyxovirus families. Like ALSV
Env, the fusion proteins of retro-, paramyxo-, and orthomyxoviruses are
proteolytically processed from a precursor protein into the mature
receptor binding and TM subunits. The TM subunits of these fusion
proteins generally contain a stretch of hydrophobic amino acids at
their amino termini. In several cases, this region has been implicated
in viral fusion activity and has thus been termed the fusion peptide.
In general, fusion peptides (i) are 15 to 25 amino acids in length,
(ii) are relatively hydrophobic, (iii) can be modeled as an alpha helix
with the bulky hydrophobic residues lying on one face of the helix, and
(iv) are rich in alanine and glycine (31). Where studied,
the fusion peptide can be labeled by photoactivatable phospholipids in
target membranes (4, 15), and mutations that introduce
changes at hydrophobic residues impair or abolish fusion activity
(8, 10, 32, 36). Fusion peptides are not always at the N
terminus; internal fusion peptides have been identified in the Semliki
Forest virus (SFV) and vesicular stomatitis virus (VSV) fusion proteins (20, 32, 36). Internal fusion peptides generally contain a
helix-breaking residue such as proline near their centers
(31). Synthetic fusion peptides adopt either
-helical or
-sheet structures in membranes (16).
By analogy with other viral fusion proteins, a sequence in ALSV Env,
residues 21 to 42 of the TM subunit, has been predicted to be its
fusion peptide. Consistent with its suggested importance, this internal
hydrophobic region is highly conserved among the different ALSV
subgroups. Furthermore, Ebola virus, a member of the filovirus family
whose envelope glycoprotein bears striking resemblance to the TM
subunit of ALSV Env, contains a candidate fusion peptide at an
analogous location (9). The candidate fusion peptide of ALSV
Env, however, has not yet been subjected to experimental analysis.
We tested the role of the candidate fusion peptide of the Env of ALSV-A
(Env A) by mutating three of its hydrophobic residues to charged
residues. The effects of these mutations on the processing, cell
surface expression, oligomerization, and receptor binding of Env as
well as the ability of the mutant Envs to mediate infection and
cell-cell fusion were examined. Our findings are fully consistent with
the prediction that this hydrophobic region serves as the fusion
peptide of ALSV Env.
 |
MATERIALS AND METHODS |
Recombinant DNA and plasmids.
Plasmids pCB6-Env A, pCB6-Env
C, pCB6-Env Acl, and pCB6-Tva have been described previously (12,
13). Mutations within the putative fusion region were created by
oligonucleotide-directed site-specific mutagenesis (17) on
single-stranded preparations of Env A cDNA which had been cloned into
the BamHI site of Bluescript. The oligonucleotides used were
Glu 1 (5'CTTTGGGGTCCTACAGCTCGAGAATTTGCATCTATCTTAGCCCCGGGG3'), Glu 2 (5'GCATCTATCTTAGCCCCGGGGGAAGCTGCAGCGCAAGCCTTAAGA3'),
Glu 3 (5'CAAGCCTTAAGAGAAGAAGAGAGGCTAGCCTGTTGGTCCG3'),
Lys 1 (5'CTTTGGGGTCCTACAGCAAGAAAATTTGCATCGATCTTAGCCCCGGGG3'), Lys
2 (5'GCATCTATCTTAGCCCCGGGGAAAGCTGCAGCGCAAGCCTTAAGA3'), and Lys 3 (5'CAAGCCTTAAGAGAAAAAGAGCGCCTAGCCTGTTGGTCCG3').
The oligonucleotides were designed to encode the altered
amino acid as well as a new restriction site for rapid detection of
mutants. Mutant plasmids were sequenced to confirm the fidelity of
mutagenesis and then subcloned into the BamHI site of pCB6.
The murine leukemia virus (MLV) Gag-Pol expression plasmid pHIT60 and
the lacZ expression plasmid pHIT111 were gifts from Alan
Kingsman. The pOS8 plasmid, containing lacZ under the T7
promoter, was a gift from Bernard Moss.
Antibodies.
The rabbit polyclonal antibodies against the
carboxy-terminal cytoplasmic tails of Env A and Env C have been
described previously (12). The rabbit polyclonal antiserum
anti-Ngp37 was raised against a peptide corresponding to the first 17 residues of the amino terminus of the TM subunit. Antibodies were
affinity purified against the corresponding peptide coupled to a
SulfoLink column (Pierce Chemical Company, Rockford, Ill.) according to
the manufacturer's instructions. The rat anti-MLV Gag monoclonal
antibody was obtained from culture supernatants of a hybridoma cell
line purchased from the American Type Culture Collection. Donkey
anti-rabbit (Amersham, Arlington Heights, Ill.) and goat anti-rat
(Jackson ImmunoResearch Laboratories, West Grove, Pa.) secondary
antibodies coupled to horseradish peroxidase (HRP) were used for
Western blot analyses.
Cells, transfections, production of pseudotyped viruses, and
virus titration.
Stable NIH 3T3 cell lines were established by
transfection of pCB6 constructs, using the calcium phosphate
precipitation method (33), and by selection of
Geneticin-resistant colonies as described previously (12,
13). Single-cell clones of the fusion peptide mutant cell lines
were obtained by limiting dilution. All stable NIH 3T3 cell lines and
293T cells were maintained in Dulbecco's modified Eagle's medium
(DMEM) containing 10% supplemented calf serum (SCS; HyClone, Ogden,
Utah) and 500 mg of Geneticin per liter. To induce higher levels of
protein expression, cells were treated with sodium butyrate overnight:
5 mM for Env Acl; 10 mM for Tva, Glu 1, Glu 2, Lys 1, and Lys 2; 15 mM
for Glu 3; 20 mM for Lys 3; and 25 mM for Env A.
The three-plasmid transfection method was used to produce
replication-incompetent (MLV) ALSV pseudotyped virus (26).
293T cells in 10-cm-diameter plates were transfected by the calcium phosphate precipitation method when ~50 to 70% confluent with a
total of 30 µg of DNA consisting of 10 µg each of pHIT60 (Gag-Pol), pHIT111 (lacZ), and pCB6-Env. All of these plasmids contain
both a cytomegalovirus promoter and a simian virus 40 ori.
Cells were treated with 10 mM sodium butyrate 24 h after
transfection. Viral supernatants were harvested 48 h
posttransfection, and supernatants were centrifuged at 1,500 × g for 10 min at room temperature to remove cell debris.
To assay for ALSV Env-mediated infection, serial dilutions of the
pseudotype viral supernatants were added to Tva-expressing 3T3 cells
plated on six-well dishes at a density of 2 × 105
cells per well the day before the infection; 48 h postinfection, cells were fixed and stained with
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal;
Boehringer Mannheim, Indianapolis, Ind.) as previously described
(24) to identify infected cells.
Envelope incorporation into virus.
To check incorporation of
wild-type (wt) and mutant Envs into (MLV) ALSV pseudotyped viruses,
293T cell viral supernatants were centrifuged at 1,500 × g for 10 min at room temperature to remove cell debris.
Viral supernatants (8 ml) were centrifuged at 4°C through 20%
sucrose for 2 h at 100,000 × g in a Beckman SW41
rotor. Pellets were resuspended in Laemmli sample buffer, boiled,
analyzed on a Western blot probed with either the anti-A tail or
anti-MLV Gag antibody, and visualized by enhanced chemiluminescence (ECL; Amersham). All blots were exposed in the linear range. To confirm
Env incorporation, wt, Glu 1, Glu 2, and Glu 3 viral pellets were
resuspended in 200 µl of TE buffer (5 mM Tris-hydrochloride, 1 mM
EDTA [pH 8.6]) with brief sonication. The samples were then layered
onto a 15 to 60% linear sucrose gradient in TE buffer and centrifuged
at 4°C for 3 h at 250,000 × g in a Beckman SW41 rotor. Fractions of 500 µl were collected, precipitated with
chloroform-methanol (16a), and analyzed on a Western blot
probed with the anti-A tail antibody and a donkey anti-rabbit-HRP
secondary antibody. Blots were then incubated for 30 min at 70°C in
stripping buffer (2% sodium dodecyl sulfate [SDS], 100 mM
2-mercaptoethanol, a 62.5 mM Tris [pH 6.8]) to remove primary and
secondary antibodies from the membranes. Membranes were reprobed with
secondary antibody, incubated with ECL detection reagents, and exposed
to film to ensure removal of any potential cross-reacting antibodies.
Blots were then reprobed with the anti-MLV Gag antibody and a goat
anti-rat-HRP secondary antibody and visualized by ECL.
Cell surface labeling, immunoprecipitation,
coimmunoprecipitation, and thermolysin digestion assay.
After
induction with sodium butyrate for 16 to 18 h, cells expressing
either Env or Tva were labeled with the membrane-impermeant biotinylation reagent NHS-LC-biotin (Pierce). Cells were lysed, and
proteins were immunoprecipitated or coimmunoprecipitated with the
anti-A tail antibody as described previously (13).
Immunoprecipitates were washed and processed for sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis (PAGE) or were used in a
thermolysin digestion assay as described previously (13).
The soluble Tva (sTva) used in the thermolysin assay was a gift from
Paul Bates. Following electrophoresis, proteins were transferred to
nitrocellulose and probed with HRP coupled to streptavidin (Pierce) to
detect biotinylated proteins. The HRP signal was detected by ECL.
Analysis of oligomer formation.
To determine the oligomeric
state of the Env proteins, cell lysates, prepared as described in
reference 14, containing biotinylated Env proteins
were layered onto a 10 to 30% linear sucrose gradient in
HEPES-buffered saline containing 40 mM octylglucoside and centrifuged in a Beckman SW41 rotor for 17 h at 275,000 × g
at 4°C. The gradient was fractionated and processed for the detection
of Env proteins as described previously (14).
Fusion assay.
The fusion assay used is a modified version of
that reported by Nussbaum et al. (22). 293T cells were
cotransfected as described above with pOS8 and a pCB6-Env vector or
pCB6-Tva; 16 to 18 h before the fusion assay, six-well dishes of
Tva- or Env-expressing 3T3 cells were infected with the modified
vaccinia virus Ankara (MVA) (34) at a multiplicity of
infection of approximately 10 for 30 min at 37°C in DMEM supplemented
with 2% SCS. Cells were then washed twice with DMEM-10% SCS and
incubated for 16 to 18 h at 31°C in DMEM-10% SCS supplemented
with 100 µg of cytosine
-D-arabinofuranoside (Ara-C;
Sigma, St. Louis, Mo.) per ml. Uninfected Env- or Tva-expressing 293T
cells were lifted off the dish with calcium- and magnesium-free
phosphate-buffered saline (PBS), centrifuged, resuspended in DMEM-10%
SCS containing 100 µg of Ara-C per ml, and then added to vaccinia
virus-infected Tva- or Env-expressing cells. The cell mixtures were
incubated at 37°C for 12 h. Cells were analyzed for
-galactosidase activity either by staining with X-Gal or by
measuring
-galactosidase activity as described below. MVA was a gift
from Bernard Moss.
Analysis of
-galactosidase activity.
Following the fusion
assay, cells were lifted off the dish, pelleted, and lysed in 50 µl
of lysis buffer (1% Nonidet P-40 in 130 mM NaCl-20 mM HEPES [pH
7.4]). A 5- to 10-µl aliquot of the cell lysate was diluted in 90 µl of lysis buffer containing 0.1 mg of 4-methylumbelliferyl
galactoside (MUG; Molecular Probes, Eugene, Oreg.) per ml and incubated
at 37°C for 4 min. The reactions were quenched with 2 ml of 0.2 M
glycine (pH 10.0), and the fluorescence in each sample was determined
in an LS-5B fluorimeter (Perkin-Elmer, San Jose, Calif.) with the
excitation and emission wavelengths set at 365 and 450 nm,
respectively.
Flow cytometry.
Approximately 2 × 105
transiently transfected 293T cells were incubated on ice with the
anti-Ngp37 antibody in a total volume of 100 µl of PBS-2% fetal
calf serum (FCS) for 30 min. Cells were washed twice in PBS and then
incubated with fluoresceinated goat anti-rabbit antibody (Jackson
ImmunoResearch Laboratories) in 100 µl of PBS-2% FCS on ice. After
30 min, cells were washed twice with PBS, resuspended in PBS containing
2% paraformaldehyde, and analyzed at the University of Virginia FACS
(fluorescence-activated cell sorting) Core Facility, using a FACScan
flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose,
Calif.).
 |
RESULTS AND DISCUSSION |
Design of mutant Env proteins.
Sequences are available for the
Env proteins of four of the five major ALSV subgroups. Analysis of
these sequences revealed a highly conserved hydrophobic region near the
amino terminus of the TM subunit (amino acids 21 to 42; Fig.
1A and B). This region is also strikingly
similar in relative location and overall hydrophobicity to the
predicted fusion peptide of the Ebola virus envelope glycoprotein
(9). By analogy with other viral fusion proteins, this
region is predicted to be the fusion peptide of ALSV Env. Similar to
many fusion peptides, this region displays a hydrophobic face when
modeled as an alpha helix (Fig. 1C). To examine the importance of this
region, we engineered six mutations that replaced the hydrophobic
residues Ile-21, Val-30, and Ile-39 (marked as positions 1, 2, and 3)
on the hydrophobic face of the modeled helix with the charged residues
glutamic acid or lysine. We predicted that insertion of a charged
residue would disrupt the hydrophobicity of the fusion peptide and
therefore impair its ability to interact with membranes and initiate
fusion. We chose the charged amino acids glutamic acid and lysine since
they have side chain volumes similar to those of the replaced amino acids valine and isoleucine and display either a negative or a positive
charge. We refer to the mutant Env proteins as Glu 1, Glu 2, Glu 3, Lys
1, Lys 2, and Lys 3, with the name designating the amino acid and
position of the substitution (Fig. 1C). Note that although we have
modeled this region as an alpha helix, it is quite possible that part
or all of this region adopts alternate structures either before or
during fusion (16).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
ALSV putative fusion peptide region. (A) Overlay of the
hydropathy plots of the TM subunits of Env glycoproteins of subgroups A
(Schmidt-Ruppin), C (Prague), D (Schmidt-Ruppin), and E (RAV-0) ALSV.
Arrow points to the candidate fusion peptide region. *, TM domain.
(B) Amino acid sequence of the candidate fusion peptide region in four
ALSV subgroups. , identical amino acid at that position. (C)
Putative fusion peptide region of ALSV-A modeled as an alpha helix. The
hydrophobic face is outlined and has an average hydrophobicity index of
1.01. The position 1, 2, and 3 amino acids are circled. As discussed in
the text, this region may adopt other structures either before or
during fusion.
|
|
Expression, processing, and oligomerization of mutant Env
proteins.
Because the designed mutations are within a highly
conserved region that may be important for protein structure, we first characterized the expression, processing, and oligomerization of the
mutant Envs. Stable NIH 3T3 cell lines expressing each of the mutant
proteins were established. After induction with sodium butyrate for 16 to 18 h, cells were lysed and analyzed by Western blotting with an
antibody against the cytoplasmic tail of Env A to assess total Env
expression. Alternatively, cells were labeled with the
membrane-impermeant reagent NHS-LC-biotin, lysed, and
immunoprecipitated with anti-A tail antibody to assess cell surface
forms of Env. As shown in Fig. 2A, a Pr95
polypeptide, similar in mobility to wt Pr95, was expressed in all of
the mutant cell lines. The proteins were processed to the mature form
since a TM subunit similar in mobility to the wt TM was detected in each mutant. Glu 1, Glu 2, Lys 1, and Lys 2 were processed and transported to the cell surface similar to wt Env since only mature SU
and TM proteins were detected at the cell surface (Fig. 2B). The
position 3 mutants were also expressed as mature protein at the cell
surface. However, in these cases processing was less efficient, since
some precursor (a band similar in size to Pr95) was transported to the
surface. We next examined oligomerization of the mutant proteins. Cells
were labeled with the membrane-impermeant biotinylating reagent, lysed,
and subjected to sucrose density centrifugation (Fig.
3). All of the mutant proteins sedimented to a position similar to that of wt Env, consistent with trimer formation (5, 14). For all mutants except Glu 3 and Lys 3, only the mature protein was observed in the trimer fractions. For Glu 3 and Lys 3, some trimerized Pr95 was found as well.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of mutant proteins in stable NIH 3T3 cell
lines. (A) Lysates of Env-expressing NIH 3T3 cells were boiled and
reduced in sample buffer, separated by SDS-PAGE (11.5% gel),
transferred to nitrocellulose, and Western blotted with anti-A tail
antibodies. (B) A parallel set of Env-expressing cells were
biotinylated with the membrane-impermeant reagent NHS-LC-biotin, lysed,
and immunoprecipitated with anti-A tail antibodies as described in
Materials and Methods. Immunecomplexes were analyzed by SDS-PAGE (11%
gel), transferred to nitrocellulose, probed with streptavidin-HRP, and
detected by ECL. The SU, TM, and Pr95 proteins migrated as shown.
|
|

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 3.
Sucrose density centrifugation analysis of cell surface
Env proteins. Env-expressing NIH 3T3 cells were biotinylated as
described in the legend to Fig. 2B, lysed, and subjected to sucrose
gradient centrifugation as described in Materials and Methods. After
centrifugation, fractions were collected, immunoprecipitated with an
anti-A tail antibody, subjected to SDS-PAGE (9% gel), and transferred
to nitrocellulose. Biotinylated proteins were detected as described in
the legend to Fig. 2B. Fraction 1 indicates the top of the gradient.
|
|
In summary, all of the mutant Env proteins were processed,
oligomerized, and expressed at the cell surface similarly to wt Env
with the exception of the position 3 mutants, which were less efficiently processed and therefore expressed some precursor at the
cell surface. Less efficient processing of the Glu 3 and Lys 3 mutants may be an indication of imprecise protein folding.
Ability of mutant Envs to interact with receptor and change
conformation.
Tva is the receptor for ALSV-A (1, 35)
and appears to be sufficient to mediate viral entry. We previously
showed that Tva binds specifically to Env A but not to Env C as
measured by a coimmunoprecipitation assay (12). We also
showed that upon interaction with sTva, a soluble form of the Tva
ectodomain, Env A undergoes a conformational change, demonstrated by
the generation of a specific thermolysin digestion product of the SU
subunit termed SU* (13). We tested whether the mutant Env
proteins were able to bind Tva and, if so, whether they could undergo
the receptor-induced conformational change.
To assess the ability of the mutant proteins to interact with Tva, we
performed a coimmunoprecipitation assay. As seen in Fig.
4, Tva coimmunoprecipitated with all of
the mutant Envs, demonstrating that the mutants retained the ability to
bind receptor. Tva is a highly modified protein and runs as a broad
smear on a gel with three prominent bands (1, 12). The
relative amount of the lowest-molecular-weight Tva band precipitated
varied from experiment to experiment in all samples. The mutants were
next tested in the receptor-induced conformational change assay. The position 1 and 2 mutants behaved the same as wt Env; SU* was produced to significant levels only in the presence of sTva (Fig.
5). The position 3 mutants, however, were
sensitive to thermolysin in both the absence and presence of sTva, and
SU proteins were digested almost beyond detection. To increase
sensitivity, we repeated the assays of Glu 3 and Lys 3 with three times
more starting Env protein. Nonetheless, the Glu 3 and Lys 3 proteins
were still digested by thermolysin to SU* in both the presence and
absence of sTva (Fig. 5B). SU* generated from the position 3 mutants
appeared to migrate at a slightly lower molecular weight than SU* from wt Env.

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 4.
Receptor binding activity of mutant Env proteins. NIH
3T3 cells expressing Tva were biotinylated and lysed as described in
the legend to Fig. 2B. Unlabeled lysates of cells expressing Env A, Env
C, or mutant Env A proteins were mixed with the biotinylated Tva lysate
and then immunoprecipitated with anti-A tail (or anti-C tail)
antibodies. Samples were resolved on SDS-PAGE (12% gel) and blotted to
nitrocellulose. Biotinylated proteins were detected as described in the
legend to Fig. 2B.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 5.
Thermolysin digestion of envelope proteins in the
absence and presence of sTva. (A) NIH 3T3 cells expressing Env proteins
were biotinylated with the membrane-impermeant reagent NHS-LC-biotin,
lysed, immunoprecipitated with anti-A or anti-C tail antibody, and
washed. Immunecomplexes were then subjected to thermolysin digestion in
the presence or absence of sTva as described previously
(13). Samples were boiled, separated by SDS-PAGE (11% gel),
transferred to nitrocellulose, probed with streptavidin-HRP, and
visualized by ECL. The SU and TM subunits and SU* migrate as indicated.
(B) The thermolysin digestion assay was repeated with the Glu 3 and Lys
3 mutants, using three times as much Env protein.
|
|
The findings presented in Fig. 5 suggest that the position 1 and 2 mutants change conformation in the presence of sTva like wt Env. As
shown in Fig. 5A and B, the position 3 mutants are not folded the same
way as wt Env. Certain mutations within the envelope glycoproteins of
other viruses affect protein folding. In some cases, the defect can be
overcome by incubating cells at a lower temperature (20). To
test if the apparent misfolding of Glu 3 and Lys 3 was temperature
sensitive, cells expressing Glu 3 and Lys 3 were incubated for 16 to
18 h at 28°C before being harvested for the thermolysin assay.
Results similar to those presented in Fig. 5 were obtained (data not
shown). The conformational change measured in the thermolysin assay may
be related to activation of the fusion protein. It is interesting that
SU* is seen in both the absence and presence of sTva with the position
3 mutants. This may be an indication that the position 3 Envs are
"presprung," or preactivated (3).
Infectivity of mutants.
MLV particles efficiently incorporate
ALSV Env into their envelopes (19). The resulting
MLV(ALSV) pseudotypes are capable of infecting cells, but only if
they express the appropriate ALSV receptor. We tested the ability of
the mutant Envs to mediate entry of MLV(ALSV-A) pseudotypes into cells
expressing Tva as a correlate of their fusion activity. MLV(ALSV-A)
particles containing a lacZ reporter gene were made in 293T
cells by using the three-plasmid transient transfection system
(26). Briefly, the expression plasmids pHIT60 (containing
MLV gag-pol), pHIT111 (containing lacZ), and
pCB6-Env (either wt A, wt C, Acl, or a fusion peptide mutant) were
cotransfected into 293T cells. Culture supernatants were collected 2 days posttransfection and assessed for particle production and envelope
incorporation. Virus particles were pelleted from equal amounts of
culture supernatants, resuspended in sample buffer, separated by
SDS-PAGE, and Western blotted with the anti-A tail antibody (Fig.
6A). The same blot was then reprobed with the anti-MLV Gag antibody (Fig. 6B). All viral supernatants contained approximately the same number of viral particles since similar levels
of Gag were detected. All mutant Env proteins were incorporated into
virus at or near wt levels; equivalent amounts of TM protein (or Pr95
in the case of the Acl [13], a cleavage site mutant that is not processed to the mature SU and TM subunits) were detected in all of the samples.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 6.
Env incorporation into pseudotyped virus particles.
Equal amounts of 293T cell viral supernatants were centrifuged through
20% sucrose as described in Materials and Methods. (A) Pellets were
resuspended in sample buffer, boiled, analyzed on a Western blot probed
with the anti-A tail antibody, and visualized by ECL. (B) The same blot
was reprobed with the anti-Gag antibody and visualized by ECL.
|
|
To confirm Env incorporation more rigorously, wt, Glu 1, Glu 2, and Glu
3 pseudotyped virions were also analyzed by sucrose density
sedimentation. As shown in Fig. 7, wt Env
as well as each of the mutant Envs comigrated with Gag at an
approximate density of 1.15 g/ml, demonstrating that the Env proteins
were, indeed, associated with intact virions (and not, for example,
merely with plasma membrane vesicles). All of the mutant Envs appear to
be incorporated into virions at levels approximately equal to each other and to that of wt Env.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 7.
Sedimentation analysis of pseudotyped virus particles.
Equal amounts of 293T cell viral supernatants were pelleted through
20% sucrose as described in the text. Pellets were resuspended in 200 µl of TE buffer and subjected to centrifugation on a continuous 15 to
60% sucrose gradient as described in Materials and Methods. After
centrifugation, fractions were chloroform-methanol precipitated, run on
an SDS-12.5% gel, analyzed on a Western blot probed with the anti-A
tail antibody, and visualized by ECL. Blots were then stripped as
described in Materials and Methods, reprobed with the anti-Gag
antibody, and visualized by ECL. 1 denotes the top of the gradient. A
band is variably seen in fraction 1 of blots probed with the anti-Gag
antibody. We do not think this is Gag because it migrates somewhat
faster and always more broadly than Gag. No Pr95 was seen in these
viral particles.
|
|
All mutant TM proteins from the pseudotyped virions migrated at the
same apparent molecular weight as the wt TM except for the Lys 1 mutant, whose TM subunit migrated at a lower apparent molecular weight
(Fig. 6A). Use of the terminal glycosylation inhibitor
deoxymannojirimycin did not change its apparent molecular weight, and
antibodies to both the N and C termini of TM recognized the protein,
excluding the possibility of proteolysis at the termini (data not
shown). Nevertheless, since all of the mutant Env proteins were
efficiently incorporated into virus particles, if we detected any
differences in pseudotype infectivity, they could not be attributed to
differences in envelope incorporation or particle production.
It was somewhat surprising that the position 3 mutants were efficiently
incorporated into virions given the results of the thermolysin assay,
which showed that these proteins had altered folding. To test the
possibility that these mutants were folded differently in the 293T
cells or in the presence of Gag, the thermolysin assay was performed on
the Glu 3 and Lys 3 Envs harvested from pelleted virions. The results
paralleled the assay done with the stable 3T3 cell lines in that, for
the position 3 mutants, SU* was produced in both the presence and
absence of Tva (data not shown).
The pseudotyped viral particles (Fig. 6) were next used to infect NIH
3T3 cells stably expressing Tva. Infectivity was measured by in situ
staining of infected cells for
-galactosidase 2 days postinfection.
The results showed that all of the mutants were impaired in infectivity
with titers ranging from 1 to 5 orders of magnitude lower than with wt
Env (Table 1). The Acl mutant was 3 orders of magnitude lower in its ability to mediate infection. The
position 3 mutants had titers 3 to 5 orders of magnitude lower than the
wt Env titer. Given the behavior of the position 3 mutants in the
thermolysin assay, however, it is possible that their loss of
infectivity was due in part or in full to aberrant folding. The titers
of the position 1 and position 2 mutants were consistently 1 to 2 and 2 to 3 orders of magnitude lower, respectively, than the wt Env titer.
From these results, it is evident that the internal hydrophobic domain
at residues 21 to 42, particularly residues 21 to 30, plays an
important role in Env-mediated viral entry. A lysine substitution at
each position appears to have a greater effect on fusion than a
glutamic acid at the same position. The reason for this is not clear
but may relate to the fact that lysine is more hydrophilic than
glutamic acid (6) and would thereby disrupt the
hydrophobicity of the region to a greater extent.
Fusion activity of mutant Envs determined by cell-cell fusion
assay.
The vaccinia virus/bacteriophage T7 system has been used
previously to measure the fusion activity of viral envelope
glycoproteins (7, 22). The assay measures the cytoplasmic
activation of a reporter gene upon fusion of two different cell
populations. We used a modified version of this system to measure
fusion between cells expressing Env and cells expressing Tva. Briefly,
Tva-expressing 3T3 cells were infected with a modified vaccinia virus
Ankara (MVA), which encodes bacteriophage T7 RNA polymerase
(34). MVA is a highly attenuated vaccinia virus strain that
can assemble and replicate efficiently only in avian and BHK-21 cells
(3a, 28). The infected cells were then overlaid with 293T
cells which had been cotransfected with an Env expression plasmid and a
plasmid with lacZ under the control of the T7 promoter
(pOS8). Upon fusion, the lacZ gene is activated and the
amount of
-galactosidase produced can be measured either by in situ
staining or by an enzymatic assay of detergent cell lysates.
We first tested wt Env, Acl, and the position 1 and 2 mutants in the
fusion assay (Fig. 8). The Glu 3 and Lys
3 mutants were tested separately since the assay conditions had to be
modified to adjust for surface expression levels (see below). With wt
Env, blue-stained cells were readily seen (Fig. 8A) and a
-galactosidase signal well above background was also measured (Fig.
8B). These findings indicated that fusion had occurred. For Acl and all
of the position 1 and 2 mutants, no
-galactosidase activity above the mock-transfected (pOS8 alone) background was measured by either in
situ staining or the enzymatic assay (Fig. 8A and B).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 8.
Cell-cell fusion assay of Glu 1, Glu 2, Lys 1, and Lys
2. 293T cells were cotransfected with pOS8 and pCB6 vectors expressing
Env proteins; 48 h posttransfection, cells were lifted off the
dish and split into three samples that were either checked for surface
expression of envelope proteins or used in the cell-cell fusion assay.
A portion of transfected 293T cells was overlaid onto Tva-expressing
3T3 cells which had been infected with MVA. After 12 h at 37°C,
samples were either fixed and stained with X-Gal (A) or lysed and
analyzed in the MUG -galactosidase fluorometric assay (B). Results
of the -galactosidase fluorometric assay are expressed as
fluorescence units and represent averages from three replicates; bars
show standard deviations. All samples were read in the linear range of
fluorescence emission. (C) A portion of transfected 293T cells were
biotinylated with NHS-LC-biotin, lysed, and immunoprecipitated with
anti-A tail antibody. Samples were analyzed as described in the legend
to Fig. 2B. (D) Another subset of transfected 293T cells was incubated
on ice with the anti-gp37 antibody in a total volume of 100 µl
PBS-2% FCS for 30 min. Cells were washed twice in PBS and then
incubated with a fluoresceinated goat anti-rabbit antibody (Jackson
ImmunoResearch Laboratories) in 100 µl of PBS-2% FCS on ice. After
30 min, cells were washed twice with PBS, resuspended in PBS containing
2% paraformaldehyde, and analyzed on a Becton Dickinson flow
cytometer.
|
|
Since fusion is dependent on protein expression at the cell surface, we
analyzed the cells used in the fusion assay for cell surface expression
of mutant Envs. 293T cells expressing Env were biotinylated, lysed, and
immunoprecipitated with anti-A tail antibody (Fig. 8C). All of the
position 1 and 2 mutant proteins were expressed at the cell surface at
levels comparable to that of wt Env. As seen in Fig. 6, the TM form of
Lys 1 appeared to migrate at a lower molecular weight than the others.
Cell surface expression was further confirmed by FACS analysis using
the anti-Ngp37 antibody, which recognizes the first 17 N-terminal
residues of the TM domain. The results showed that all of the mutant
proteins were expressed at the cell surface at levels comparable to
that of wt Env (Fig. 8D). Thus, surface expression levels did not
account for the low fusion activity of the Glu 1, Glu 2, Lys 1, and Lys
2 proteins.
We next explored whether the low-molecular-weight form of the Lys 1 TM
was responsible for its loss of fusion. The Lys 1 TM migrates at the
same molecular weight as the wt TM when expressed in NIH 3T3 cells
(Fig. 2) as opposed to when it is expressed in 293T cells (Fig. 6A and
8C). We therefore modified the fusion assay to use 3T3 cells. Stable
3T3 cells expressing wt, Acl, or Lys 1 mutant Env were infected with
MVA and then overlaid with 293T cells transfected with pCB6-Tva and the
-galactosidase reporter plasmid. The results are seen in Fig.
9. The cell surface expression level of
Lys 1 was comparable to that of wt Env as measured by immunoprecipitation of cell surface proteins (Fig. 9A). Despite this,
Lys 1 expressed in 3T3 cells was again defective in fusion compared to
wt Env (Fig. 9B). From this finding, we conclude that the fusion defect
of Lys 1 was not due to the appearance of its TM subunit as a slightly
lower molecular weight form in 293T cells. Lys 1 can therefore be
considered a true fusion mutant.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 9.
Cell-cell fusion assay of Lys 1 mutant in 3T3 cells. NIH
3T3 cells expressing Env A, Env Acl, or Lys 1 were seeded in six-well
dishes (105 cells per well) and incubated overnight. Cells
were then infected with MVA at a multiplicity of infection of 1 as
described in Materials and Methods and incubated overnight at 31°C in
the presence of 100 µg of Ara-C per ml and sodium butyrate. Cells
were then either analyzed for surface expression of Env proteins or
used in the cell-cell fusion assay. (A) One well of a six-well dish of
infected 3T3 cells was biotinylated with NHS-LC-biotin, lysed, and
immunoprecipitated with anti-A tail antibody. Samples were analyzed as
described in the legend to Fig. 2B. (B) Infected 3T3 cells were
overlaid with 293T cells which had been cotransfected with pOS8 and
pCB6-Tva 2 days earlier. After 24 h cells, were lifted off the
dish, lysed and analyzed in the MUG -galactosidase fluorometric
assay. The data represent the averages of three replicates; bars show
standard deviations.
|
|
The position 3 mutants were tested in the cell-cell fusion assay to
corroborate the results of the infectivity assay. While the Glu 3 and
Lys 3 mutants were efficiently incorporated into virus particles, FACS
analysis showed that the surface expression levels of both mutants were
lower than the wt Env level when the same amount of input DNA was used
(data not shown). Attempts to equalize surface expression were made by
adjusting the amounts of transfected wt and mutant DNAs. Equal surface
expression levels were achieved, but equal transfection efficiencies
(percent Env-expressing cells) were never attained (Fig.
10A). This finding again suggests that
the position 3 mutant proteins are not folded exactly as wt Env and are
not transported efficiently to the cell surface in 293T cells. Even
after normalizing for lower transfection efficiencies, we detected no
fusion activity above background in the Glu 3 and Lys 3 mutants (Fig.
10B), consistent with the results from the infectivity assay. It was
not expected that placement of a charged residue at position 3 would
result in a misfolded protein since position 3 is flanked on both sides
by charged residues (Fig. 1B and C). Since the position 3 mutants
behave as if they are presprung (Fig. 5), the conservation of a
hydrophobic residue at this position may be important for maintaining
Env in a metastable prefusogenic conformation.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 10.
Cell-cell fusion assay of Glu 3 and Lys 3. 293T cells
were cotransfected with pOS8 and either pCB6-Env A, Env Acl, Glu 3, Lys
3, or pCB6 alone; 48 h posttransfection, cells were lifted off the
dish and either checked for cell surface expression or used in the
cell-cell fusion assay. (A) FACS analysis of transfected 293T cells.
(B) Transfected 293T cells were overlaid onto MVA-infected
Tva-expressing 3T3 cells. After 24 h at 37°C, samples were lysed
and analyzed in the MUG -galactosidase fluorometric assay. The data
represent the averages of three replicates; bars show standard
deviations.
|
|
Summary.
The viral fusion proteins of orthomyxo-,
paramyxo-, and retroviruses are arranged similarly, with a mature
transmembrane and surface subunit being generated by proteolytic
processing of a precursor protein. The newly revealed N terminus of the
TM subunit contains the fusion peptide, a hydrophobic domain that
interacts with the target membrane to initiate fusion (16).
Internal fusion peptides are not as common but have been identified in
the E1 and G proteins of SFV and VSV, respectively (4, 20, 32, 36). Mutations within these latter fusion peptides affect
membrane fusion. Photolabeling experiments have shown that, like the
hemagglutinin fusion peptide (15), the VSV fusion
peptide interacts hydrophobically with target membranes (4).
Unlike most retroviruses, ALSV has a candidate fusion peptide internal
to the N terminus of its TM subunit. Using site-directed mutagenesis,
we have made six mutations in this region, each of which replaces a
hydrophobic amino acid with a charged amino acid of approximately the
same side chain volume. The mutant proteins all showed decreased fusion
activity in both infectivity and cell-cell fusion assays. The mutations
at positions 1 and 2 clearly impaired Env-mediated fusion without
affecting its folding, oligomerization, cell surface expression,
receptor binding, or ability to undergo a receptor-induced
conformational change (Table 2). The
behavior of the position 1 and 2 mutants therefore supports the
contention that amino acids 21 to 42 of the TM subunit is the ALSV Env
fusion peptide. Consistent with this is the fact that the Glu 2 mutant is significantly impaired in its ability to bind to liposomes when
triggered by soluble receptor (16a). The mutants at position 3 had the greatest impairment in infectivity, but it is difficult to
accurately assess their fusion phenotypes, as these proteins are not
folded exactly as wt Env. In fact, our analysis of thermolysin susceptibility presented in Fig. 5 suggests that the position 3 mutants
may be presprung into an inactive conformation much in the way that low
pH pretreatment of influenza virus and SFV inactivates their fusion
proteins (21, 27, 30).
A structural model for the ALSV TM subunit is very similar to that for
the carboxy-terminal 181 amino acids of the Ebola virus glycoprotein
(9). Our results suggest that the analogous region in the
Ebola virus glycoprotein (residues 608 to 623) may function as a fusion
peptide.
 |
ACKNOWLEDGMENTS |
We thank Sue Delos for generating and characterizing the
anti-Ngp37 antibody, Joanna Gilbert for help in designing the
oligonucleotides used for mutagenesis, Paul Bates and John Balliet for
supplying sTva, Bernard Moss and Linda Wyatt for supplying MVA and pOS8 and for advice on using MVA, Alan Kingsman for supplying the pHIT pseudotyping vectors, and William Ross at the UVA FACS Core Facility for performing the flow cytometry analysis.
This work was supported by grant A122470 from the National Institutes
of Health to J.M.W. and a Howard Hughes predoctoral fellowship to
L.D.H.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cell Biology, University of Virginia Health Sciences Center, Box 439, Charlottesville, VA 22908. Phone: (804) 924-2593. Fax: (804) 982-3912. E-mail: jw7g{at}virginia.edu.
 |
REFERENCES |
| 1.
|
Bates, P.,
J. A. T. Young, and H. E. Varmus.
1993.
A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor.
Cell
74:1043-1051[Medline].
|
| 2.
|
Bentz, J. (ed.).
1993.
.
Viral fusion mechanisms.
CRC Press, Inc., Boca Raton, Fla.
|
| 3.
|
Carr, C. M., and P. S. Kim.
1993.
A spring-loaded mechanism for the conformational change of influenza hemagglutinin.
Cell
73:823-832[Medline].
|
| 3a.
|
Carroll, M. W., and B. Moss.
1997.
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman cell line.
Virology
238:198-211[Medline].
|
| 4.
|
Durrer, P.,
Y. Gaudin,
R. W. H. Ruigrok,
R. Graf, and J. Brunner.
1995.
Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses.
J. Biol. Chem.
270:17575-17581[Abstract/Free Full Text].
|
| 5.
|
Einfeld, D., and E. Hunter.
1988.
Oligomeric structure of a prototypic retrovirus glycoprotein.
Proc. Natl. Acad. Sci. USA
85:8688-8692[Abstract/Free Full Text].
|
| 6.
|
Eisenberg, D.
1984.
Three-dimensional structure of membrane and surface proteins.
Annu. Rev. Biochem.
53:595-623[Medline].
|
| 7.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 8.
|
Freed, E. O.,
D. J. Myers, and R. Risser.
1990.
Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
Proc. Natl. Acad. Sci. USA
87:4650-4654[Abstract/Free Full Text].
|
| 9.
|
Gallaher, W. R.
1996.
Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses.
Cell
85:477-478[Medline].
|
| 10.
|
Gething, M.-J.,
R. W. Doms,
D. York, and J. M. White.
1986.
Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.
J. Cell Biol.
102:11-23[Abstract/Free Full Text].
|
| 11.
|
Gilbert, J.,
D. Mason, and J. White.
1990.
Fusion of Rous sarcoma virus with host cells does not require low pH.
J. Virol.
64:5106-5113[Abstract/Free Full Text].
|
| 12.
|
Gilbert, J. M.,
P. Bates,
H. E. Varmus, and J. M. White.
1994.
The receptor for the subgroup A avian leukosis sarcoma virus binds to subgroup A but not to subgroup C envelope glycoprotein.
J. Virol.
67:6889-6892[Abstract/Free Full Text].
|
| 13.
|
Gilbert, J. M.,
L. D. Hernandez,
J. W. Balliet,
P. Bates, and J. M. White.
1995.
Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.
J. Virol.
69:7410-7415[Abstract].
|
| 14.
|
Gilbert, J. M.,
L. D. Hernandez,
T. Chernov-Rogan, and J. M. White.
1993.
Generation of a water soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein.
J. Virol.
67:6889-6892.
|
| 15.
|
Harter, C.,
P. James,
T. Bächi,
G. Semenza, and J. Brunner.
1989.
Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide."
J. Biol. Chem.
264:6459-6464[Abstract/Free Full Text].
|
| 16.
|
Hernandez, L. D.,
L. R. Hoffman,
T. G. Wolfsberg, and J. M. White.
1996.
Virus-cell and cell-cell fusion.
Annu. Rev. Cell Dev. Biol.
12:627-661.
[Medline] |
| 16a.
|
Hernandez, L. D.,
R. J. Peters,
S. E. Delos,
J. A. T. Young,
D. A. Agard, and J. M. White.
1997.
Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.
J. Cell Biol.
139:1455-1464[Abstract/Free Full Text].
|
| 17.
|
Kunkel, T. A.,
J. D. Roberts, and R. A. Zakour.
1987.
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Methods Enzymol.
154:367-382[Medline].
|
| 18.
|
Lamb, R. A.
1993.
Paramyxovirus fusion: a hypothesis for change.
Virology
197:1-11[Medline].
|
| 19.
|
Landau, N. R., and D. R. Littman.
1992.
Packaging system for rapid production of murine leukemia virus vectors with variable tropism.
J. Virol.
66:5110-5113[Abstract/Free Full Text].
|
| 20.
|
Levy-Mintz, P., and M. Kielian.
1991.
Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.
J. Virol.
65:4292-4300[Abstract/Free Full Text].
|
| 21.
|
Marsh, M., and A. Helenius.
1989.
Virus entry into animal cells.
Adv. Virus Res.
36:107-151[Medline].
|
| 22.
|
Nussbaum, O.,
C. C. Broder, and E. A. Berger.
1994.
Fusogenic mechanisms of enveloped-virus glycoprotein analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
J. Virol.
68:5411-5422[Abstract/Free Full Text].
|
| 23.
|
Perez, L. G., and E. Hunter.
1987.
Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37.
J. Virol.
61:1609-1614[Abstract/Free Full Text].
|
| 24.
|
Sanes, J. R.,
J. L. Rubenstein, and J. F. Nicolas.
1986.
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
EMBO J.
5:3133-3142[Medline].
|
| 25.
|
Skehel, J. J.,
T. Bizebard,
P. A. Bullough,
F. M. Hughson,
M. Knossow,
D. A. Steinhauer,
S. A. Wharton, and D. C. Wiley.
1995.
Membrane fusion by influenza hemagglutinin.
Cold Spring Harbor Symp. Quant. Biol.
60:573-580[Medline].
|
| 26.
|
Soneoka, Y.,
P. M. Cannon,
E. E. Ramsdale,
J. C. Griffiths,
G. Romano,
S. M. Kingsman, and A. J. Kingsman.
1995.
A transient three-plasmid expression system for the production of high titer retroviral vectors.
Nucleic Acids Res.
23:628-633[Abstract/Free Full Text].
|
| 27.
|
Stegmann, T.,
F. P. Booy, and J. Wilschut.
1987.
Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin.
J. Biol. Chem.
262:17744-17749[Abstract/Free Full Text].
|
| 28.
|
Sutter, G., and B. Moss.
1992.
Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Proc. Natl. Acad. Sci. USA
89:10847-10851[Abstract/Free Full Text].
|
| 29.
|
Weiss, R.
1992.
Cellular receptors and viral glycoproteins involved in retrovirus entry, p. 1-108. In
J. Levy (ed.), The retroviruses, vol. 2.
Plenum Press, New York, N.Y.
|
| 30.
|
White, J.,
J. Kartenbeck, and A. Helenius.
1982.
Membrane fusion activity of influenza virus.
EMBO J.
1:217-222[Medline].
|
| 31.
|
White, J. M.
1992.
Membrane fusion.
Science
258:917-924[Abstract/Free Full Text].
|
| 32.
|
Whitt, M. A.,
P. Zagouras,
B. Crise, and J. K. Rose.
1990.
A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.
J. Virol.
64:4907-4913[Abstract/Free Full Text].
|
| 33.
|
Wigler, M.,
S. Silverstein,
L.-S. Lee,
A. Pellicer,
Y.-C. Cheng, and R. Axel.
1977.
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.
Cell
11:223-232[Medline].
|
| 34.
|
Wyatt, L. S.,
B. Moss, and S. Rozenblatt.
1995.
Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
Virology
210:202-205[Medline].
|
| 35.
|
Young, J. A.,
P. Bates, and H. E. Varmus.
1993.
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses.
J. Virol.
67:1811-1816[Abstract/Free Full Text].
|
| 36.
|
Zhang, L., and H. P. Ghosh.
1994.
Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G.
J. Virol.
68:2186-2193[Abstract/Free Full Text].
|
J Virol, April 1998, p. 3259-3267, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Amberg, S. M., Netter, R. C., Simmons, G., Bates, P.
(2006). Expanded Tropism and Altered Activation of a Retroviral Glycoprotein Resistant to an Entry Inhibitor Peptide. J. Virol.
80: 353-359
[Abstract]
[Full Text]
-
Sainz, B. Jr., Rausch, J. M., Gallaher, W. R., Garry, R. F., Wimley, W. C.
(2005). Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein. J. Virol.
79: 7195-7206
[Abstract]
[Full Text]
-
Matsuyama, S., Delos, S. E., White, J. M.
(2004). Sequential Roles of Receptor Binding and Low pH in Forming Prehairpin and Hairpin Conformations of a Retroviral Envelope Glycoprotein. J. Virol.
78: 8201-8209
[Abstract]
[Full Text]
-
Melikyan, G. B., Barnard, R. J. O., Markosyan, R. M., Young, J. A. T., Cohen, F. S.
(2004). Low pH Is Required for Avian Sarcoma and Leukosis Virus Env-Induced Hemifusion and Fusion Pore Formation but Not for Pore Growth. J. Virol.
78: 3753-3762
[Abstract]
[Full Text]
-
Earp, L. J., Delos, S. E., Netter, R. C., Bates, P., White, J. M.
(2003). The Avian Retrovirus Avian Sarcoma/Leukosis Virus Subtype A Reaches the Lipid Mixing Stage of Fusion at Neutral pH. J. Virol.
77: 3058-3066
[Abstract]
[Full Text]
-
Ochsenbauer-Jambor, C., Delos, S. E., Accavitti, M. A., White, J. M., Hunter, E.
(2002). Novel Monoclonal Antibody Directed at the Receptor Binding Site on the Avian Sarcoma and Leukosis Virus Env Complex. J. Virol.
76: 7518-7527
[Abstract]
[Full Text]
-
Stiasny, K., Allison, S. L., Schalich, J., Heinz, F. X.
(2002). Membrane Interactions of the Tick-Borne Encephalitis Virus Fusion Protein E at Low pH. J. Virol.
76: 3784-3790
[Abstract]
[Full Text]
-
Taylor, G. M., Gao, Y., Sanders, D. A.
(2001). Fv-4: Identification of the Defect in Env and the Mechanism of Resistance to Ecotropic Murine Leukemia Virus. J. Virol.
75: 11244-11248
[Abstract]
[Full Text]
-
Stiasny, K., Allison, S. L., Mandl, C. W., Heinz, F. X.
(2001). Role of Metastability and Acidic pH in Membrane Fusion by Tick-Borne Encephalitis Virus. J. Virol.
75: 7392-7398
[Abstract]
[Full Text]
-
Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W., Heinz, F. X.
(2001). Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E. J. Virol.
75: 4268-4275
[Abstract]
[Full Text]
-
Taguchi, F., Shimazaki, Y. K.
(2000). Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity. J. Gen. Virol.
81: 2867-2871
[Abstract]
[Full Text]
-
Delos, S. E., White, J. M.
(2000). Critical Role for the Cysteines Flanking the Internal Fusion Peptide of Avian Sarcoma/Leukosis Virus Envelope Glycoprotein. J. Virol.
74: 9738-9741
[Abstract]
[Full Text]
-
Balliet, J. W., Gendron, K., Bates, P.
(2000). Mutational Analysis of the Subgroup A Avian Sarcoma and Leukosis Virus Putative Fusion Peptide Domain. J. Virol.
74: 3731-3739
[Abstract]
[Full Text]
-
Delos, S. E., Gilbert, J. M., White, J. M.
(2000). The Central Proline of an Internal Viral Fusion Peptide Serves Two Important Roles. J. Virol.
74: 1686-1693
[Abstract]
[Full Text]
-
Ito, H., Watanabe, S., Sanchez, A., Whitt, M. A., Kawaoka, Y.
(1999). Mutational Analysis of the Putative Fusion Domain of Ebola Virus Glycoprotein. J. Virol.
73: 8907-8912
[Abstract]
[Full Text]
-
Qiao, H., Armstrong, R. T., Melikyan, G. B., Cohen, F. S., White, J. M.
(1999). A Specific Point Mutant at Position 1 of the Influenza Hemagglutinin Fusion Peptide Displays a Hemifusion Phenotype. Mol. Biol. Cell
10: 2759-2769
[Abstract]
[Full Text]